C
grade
A brain-targeted biomimetic iron-porphyrin covalent organic framework nanoplatform for Alzheimer's disease: synergistic intervention via antioxidant, Aβ-regulating and immunomodulatory effects.
GHK-Cu · Journal of colloid and interface science · 2026 · Observational · Preclinical
This study presents a novel nanoplatform that targets multiple pathways in Alzheimer's disease, showing promise in animal models without making definitive treatment claims.
Copper-ion chelation rate of 41.78%.